4.1 Article

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Volume 38, Issue 1, Pages S93-S113

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PGP.0000000000000524

Keywords

Endometrial carcinoma; Prognosis; Pathology; Myometrium invasion; MELF; Cervical stromal invasion; Lymphovascular space invasion; Adnexal involvement; Staging

Ask authors/readers for more resources

Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication is to ensure that patients receive optimal treatment and are neither overtreated nor undertreated, thereby improving patient outcomes overall. Patients with EC can be categorized into prognostic risk groups based on clinicopathologic findings. Other than tumor type and grade, groupings and recommended management algorithms may take into account age, body mass index, stage, and presence of lymphovascular space invasion. The molecular classification of EC that has emerged from the Cancer Genome Atlas (TCGA) study provides additional, potentially superior, prognostic information to traditional histologic typing and grading. This classifier does not, however, replace clinicopathologic risk assessment based on parameters other than histotype and grade. It is envisaged that molecular and clinicopathologic prognostic grouping systems will work better together than either alone. Thus, while tumor typing and grading may be superseded by a classification based on underlying genomic abnormalities, accurate assessment of other pathologic parameters will continue to be key to patient management. These include those factors related to staging, such as depth of myometrial invasion, cervical, vaginal, serosal surface, adnexal and parametrial invasion, and those independent of stage such as lymphovascular space invasion. Other prognostic parameters will also be discussed. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

Alba Mota, Sara S. Oltra, Pier Selenica, Cristian P. Moiola, Carlos Casas-Arozamena, Carlos Lopez-Gil, Eva Diaz, Sonia Gatius, Maria Ruiz-Miro, Ana Calvo, Alejandro Rojo-Sebastian, Pablo Hurtado, Roberto Pineiro, Eva Colas, Antonio Gil-Moreno, Jorge S. Reis-Filho, Laura Muinelo-Romay, Miguel Abal, Xavier Matias-Guiu, Britta Weigelt, Gema Moreno-Bueno

Summary: Analyzing intratumor genetic heterogeneity (ITGH) in endometrial carcinoma (EC) using sequencing technologies can help understand tumor evolution, prognosis, and guide personalized therapy. This study characterized the spatial and temporal heterogeneity of nine ECs and identified somatic mutations through whole-exome sequencing. The phylogenetic tree analysis revealed the correlation between tumor progression, prognosis, and recurrent disease, and also guided the selection of personalized therapy for a patient with ambiguous EC.

ONCOGENE (2022)

Article Pathology

Comparison of the Idylla (TM) MSI assay with the Promega (TM) MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

Sonia Gatius, Ana Velasco, Mar Varela, Miriam Cuatrecasas, Pedro Jares, Lisa Setaffy, Benjamin Bonhomme, Almudena Santon, Kristina Lindemann, Sabrina Croce, Ben Davidson, Sigurd Lax, Jose Palacios, Xavier Matias-Guiu

Summary: The determination of microsatellite instability (MSI) and mismatch repair deficiency (MMRD) is crucial for the diagnosis and prognosis of endometrial carcinomas (ECs), identification of Lynch syndrome carriers, and selection of patients for immunotherapy. The Idylla(TM) MSI assay is a rapid and highly concordant test for MSI in EC. It does not require non-tumoral tissue and can be performed in about 150 min.

VIRCHOWS ARCHIV (2022)

Article Environmental Sciences

Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age-Period-Cohort Modelling

Paula Peremiquel-Trillas, Jon Frias-Gomez, Laia Alemany, Alberto Ameijide, Mireia Vilardell, Rafael Marcos-Gragera, Sonia Paytubi, Jordi Ponce, Jose Manuel Martinez, Marta Pineda, Joan Brunet, Xavier Matias-Guiu, Maria Carulla, Jaume Galceran, Angel Izquierdo, Josep M. Borras, Laura Costas, Ramon Cleries

Summary: This study predicts a decline in ovarian cancer incidence and mortality rates in Catalonia by 2030, particularly among women aged 45 years and above. The risk of developing ovarian cancer decreases with later birth year, though there is a rebound among women born in the 1980s. Decreased mortality rates were observed during the period of diagnosis and death, but older women still have higher ovarian cancer mortality compared to other age groups.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Computer Science, Artificial Intelligence

NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images

Daniel Jimenez-Sanchez, Mikel Ariz, Hang Chang, Xavier Matias-Guiu, Carlos E. de Andrea, Carlos Ortiz-de-Solorzano

Summary: NaroNet is a deep learning framework that models the multi-scale tumor microenvironment from multiplex-stained cancer tissue images and provides patient-level interpretable predictions. The model learns the influence of cell phenotypes, cell neighborhoods, and neighborhood interactions on predicting the correct label through unsupervised learning.

MEDICAL IMAGE ANALYSIS (2022)

Article Public, Environmental & Occupational Health

Night work, chronotype and risk of endometrial cancer in the Screenwide case-control study

Laura Costas, Jon Frias-Gomez, Yolanda Benavente Moreno, Paula Peremiquel-Trillas, Alvaro Carmona, Javier de Francisco, Victor Cano, Sonia Paytubi, Beatriz Pelegrina, Jose Manuel Martinez, Marta Pineda, Joan Brunet, August Vidal, Xavier Matias-Guiu, Xavier Bosch, Jordi Ponce, Manolis Kogevinas, Silvia De Sanjose, Laia Alemany

Summary: After adjusting for potential confounders, an inverse but not statistically significant association was found between night shift work and endometrial cancer (OR=0.64; 95% CI=0.35 to 1.16). The associations were independent of shift type (permanent or rotating nights) or duration of night work. No statistically significant association was observed between endometrial cancer and sleep duration, while inconsistent patterns were seen for chronotype and endometrial cancer risk.

OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2022)

Article Multidisciplinary Sciences

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

Anna Ruiz-Mitjana, Raul Navaridas, Maria Vidal-Sabanes, Aida Perramon-Gueell, Andree Yeramian, Isidre Felip, Nuria Eritja, Joaquim Egea, Mario Encinas, Xavier Matias-Guiu, Xavier Dolcet

Summary: The extracellular matrix and cell polarity are crucial for maintaining cellular homeostasis and preventing carcinogenesis. This study investigates the role of extracellular matrix in the cellular response to TGF-beta. It shows that the absence of extracellular matrix inhibits apoptosis and promotes epithelial-to-mesenchymal transition in response to TGF-beta. The molecular mechanisms underlying these cellular responses involve AKT, ERK, and SMAD pathways.

SCIENTIFIC REPORTS (2022)

Article Oncology

Vulvar High-Grade Squamous Intraepithelial Lesions Treated with Imiquimod: Can Persistence of Human Papillomavirus Predict Recurrence?

Maria-Eulalia Fernandez-Montoli, Fatima Heydari, Fabrizia Lavecchia, Miquel-Angel Pavon, Esther Guerra, Xavier Matias-Guiu, Maria-Dolores Marti, Sara Tous

Summary: This retrospective study aimed to assess the long-term response to imiquimod in patients with vulvar HSIL and to analyze the role of HPV in the persistence or recurrence of vulvar HSIL after imiquimod treatment. The results showed that imiquimod effectively treated vulvar HSIL, with a higher number of complete and partial responses. Patients who had a partial or no response to imiquimod had a higher risk of recurrence, especially in immunosuppressed patients. The study also found that patients who tested positive for HPV after imiquimod treatment were more likely to experience recurrence.

CANCERS (2022)

Article Oncology

The WID-EC test for the detection and risk prediction of endometrial cancer

James E. Barrett, Allison Jones, Iona Evans, Chiara Herzog, Daniel Reisel, Adeola Olaitan, Tim Mould, Nicola MacDonald, Konstantinos Doufekas, Claire Newton, Emma J. Crosbie, Line Bjorge, Nicoletta Colombo, Lukas Dostalek, Laura Costas, Paula Peremiquel-Trillas, Jordi Ponce, Xavier Matias-Guiu, Michal Zikan, David Cibula, Jiangrong Wang, Karin Sundstroem, Joakim Dillner, Martin Widschwendter

Summary: To reduce the morbidity caused by aggressive treatment for advanced endometrial cancer, it is necessary to identify women at risk and detect the cancer earlier. A new test called WID-EC based on DNA methylation was developed and validated in different sets of samples, showing promising results in identifying women with or at risk of endometrial cancer.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Cell Biology

LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion

Yaiza Jung-Garcia, Oscar Maiques, Joanne Monger, Irene Rodriguez-Hernandez, Bruce Fanshawe, Marie-Charlotte Domart, Matthew J. Renshaw, Rosa M. Marti, Xavier Matias-Guiu, Lucy M. Collinson, Victoria Sanz-Moreno, Jeremy G. Carlton

Summary: Metastasis involves cancer cells spreading from the primary tumor to other sites. Researchers discovered increased expression of the protein LAP1 in metastatic melanoma cells, primary melanoma tumors, and metastases. They found that a shorter isoform of LAP1, LAP1C, supports constrained cell migration and invasion by allowing a weaker coupling between the nuclear envelope and the nuclear lamina. This suggests that LAP1 contributes to melanoma aggressiveness.

NATURE CELL BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

Laura Devis-Jauregui, August Vidal, Laura Plata-Pena, Maria Santacana, Sandra Garcia-Mulero, Nuria Bonifaci, Eulalia Noguera-Delgado, Nuria Ruiz, Marta Gil, Eduard Dorca, Francisco J. Llobet, Laura Coll-Iglesias, Katja Gassner, Maria Martinez-Iniesta, Ruth Rodriguez-Barrueco, Marc Barahona, Lola Marti, Francesc Vinals, Jordi Ponce, Rebeca Sanz-Pamplona, Josep M. Piulats, Ana Vivancos, Xavier Matias-Guiu, Alberto Villanueva, David Llobet-Navas

Summary: To address the clinical management challenges in endometrial cancer (EC), researchers have generated a collection of patient-derived orthoxenograft (PDOX) mouse models, which provide a valuable tool for studying and developing precision medicine in EC.

ADVANCED SCIENCE (2023)

Article Oncology

Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

Jara Palomero, Carla Panisello, Maria Lozano-Rabella, Ricky Tirtakasuma, Judit Diaz-Gomez, Daniela Grases, Helena Pasamar, Laura Arregui, Eduard Dorca Duch, Esther Guerra Fernandez, Ana Vivancos, Carlos E. de Andrea, Ignacio Melero, Jordi Ponce, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Alena Gros

Summary: Our study investigates the prevalence, phenotype, specificity and prognostic value of tumor infiltrating lymphocytes (TILs) in endometrial cancer (EC). We found that CD8(+)TILs expressing high levels of PD-1 and CD39 were associated with tumor reactivity and improved patient survival. The co-expression of inhibitory and activation markers on PD-1(hi) CD4(+) T cells was also observed, which accumulated antitumor T cells and correlated with prolonged survival in EC patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Cell Biology

Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

Giorgia Sonzini, Sofia Granados-Aparici, Sabina Sanegre, Angel Diaz-Lagares, Juan Diaz-Martin, Carlos de Andrea, Nuria Eritja, Aida Bao-Caamano, Nicolas Costa-Fraga, David Garcia-Ros, Carmen Salguero-Aranda, Ben Davidson, Rafael Lopez-Lopez, Ignacio Melero, Samuel Navarro, Santiago Ramon y Cajal, Enrique de Alava, Xavier Matias-Guiu, Rosa Noguera

Summary: In this study, digital pathology and omics analyses were used to investigate the tumor microenvironment and molecular features of uterine adenocarcinoma, uterine leiomyosarcoma, and their lung metastases. The results showed differences in the reticulin fiber scaffolding and immune cell infiltration between the invasive tumor front and metastatic tumors, which could potentially improve metastatic prediction and identify therapeutic targets.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Oncology

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer

Marike S. Lombaers, Karlijn M. C. Cornel, Nicole C. M. Visser, Johan Bulten, Heidi V. N. Kuesters-Vandevelde, Frederic Amant, Dorry Boll, Peter Bronsert, Eva Colas, Peggy M. A. J. Geomini, Antonio Gil-Moreno, Dennis van Hamont, Jutta Huvila, Camilla A. Krakstad, Arjan A. Kraayenbrink, Martin Koskas, Gemma Mancebo, Xavier Matias-Guiu, Huy M. Ngo, Brenda M. Pijlman, Maria Caroline Vos, Vit Weinberger, Marc P. L. M. W. Snijders, Sebastiaan W. S. van Koeverden, Ingfrid S. Haldorsen, Casper Reijnen, Johanna M. A. Pijnenborg

Summary: Patients with high-grade uterine cancer have a higher risk of cancer spreading to the lymph nodes compared to patients with low-grade uterine cancer. CA125, a marker detectable in blood, is associated with increased tumor spread. This study aimed to assess the predictive value of CA125 for uterine cancer spread and survival and the additional value of CT scan in high-grade uterine cancer. The findings showed that elevated CA125 was associated with advanced stage, lymph node metastasis, and a worse prognosis in high-grade uterine cancer.

CANCERS (2023)

Article Chemistry, Multidisciplinary

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

Raul Navaridas, Maria Vidal-Sabanes, Anna Ruiz-Mitjana, Gisela Altes, Aida Perramon-Guell, Andree Yeramian, Joaquim Egea, Mario Encinas, Sonia Gatius, Xavier Matias-Guiu, Xavier Dolcet

Summary: Simultaneous deletion of Pten and p53 in endometrial epithelial cells is sufficient to trigger epithelial-to-mesenchymal transition, leading to the development of metastatic uterine carcinosarcomas.

ADVANCED SCIENCE (2023)

Article Oncology

FIGO staging of endometrial cancer: 2023

Jonathan S. Berek, Xavier Matias-Guiu, Carien Creutzberg, Christina Fotopoulou, David Gaffney, Sean Kehoe, Kristina Lindemann, David Mutch, Endometrial Canc Staging Subcomm, FIGO Womens Canc Comm

Summary: Since the 2009 update of the FIGO staging system, there have been significant advances in understanding the pathologic and molecular features of endometrial cancer. The new staging system aims to better define prognostic groups and create substages to guide more appropriate treatment.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2023)

No Data Available